Advertisement

July 2015 Briefing – Allergy

0
Here are what the editors at HealthDay consider to be the most important developments in Allergy for July 2015. This roundup includes the latest...
Mobile health short message service text messages can improve medication adherence

Review: mHealth Text Messages Promote Medication Adherence

0
Nine of 13 articles show improvement in adherence rates with mobile health text messages
Nickel dermatitis has been observed in a number of children whose symptoms resolved after avoiding contact with dimethylglyoxime-positive belt buckles. These observations have been published as a case report online Aug. 3 in Pediatrics.

Case Report: Pediatric Nickel Dermatitis Caused by Belt Buckles

0
Report describes 12 children with peri-umbilical nickel dermatitis attributed to belt buckles
The American Medical Association is encouraging clinicians to share their perspectives on electronic heath records and the meaningful use program.

AMA Wants Doctor Input on EHRs, Meaningful Use

0
Doctors encouraged to share stories, e-mail Congress members
From 2014 to 2024

U.S. Health Spending Projected to Rise 5.8 Percent By 2024

0
Increase due to ACA coverage expansions, faster economic growth, population aging
Probiotic supplementation in pregnancy and early infancy can prevent infantile eczema

Probiotic Supplements May Help Prevent Infantile Eczema

0
No significant difference for prevention of asthma, wheezing, or rhinoconjunctivitis
The 2015 version of the American Board of Internal Medicine maintenance-of-certification program is expected to generate considerable costs

2015 MOC Program Expected to Cost $5.7 Billion Over 10 Years

0
Time costs account for 90 percent of maintenance of certification costs, estimated at $5.1 billion
Millions more Americans have affordable health insurance

Patients Report Improved Care Access, Better Health With ACA

0
Gains seen in how many adults have insurance and a doctor, and say they are in better health
Self- and caregiver-reported history of eczema is valid for identifying atopic dermatitis

Self-Reported Eczema Valid for Detecting Atopic Dermatitis

0
High specificity and positive predictive value for self-, caregiver-reported ever history of eczema
About 10 percent of cases where a drug does serious harm are not reported to the U.S. Food and Drug Administration within the required 15-day period

Delays Noted in the Reporting of Serious Patient Harms to FDA

0
Analysis found roughly 10 percent of cases were filed after 15-day deadline passed